GPC1 is known to function as a co-receptor/modulator of various growth factors to enhance the binding to their respective receptors [4–11], and cancer-associated fibroblasts (CAFs) are an important contributor of some of those growth factors in tumors, including FGF2 and TGFβ [36, 37]. This evidence concerns the gene FGF2 and cancer.